|
|
Article: Chiron Reduces Supply Expectations for BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. Markets.
- Article from:
- Business Wire
- Article date:
- July 15, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EMERYVILLE, Calif. -- Chiron Corporation (Nasdaq:CHIR)
--Company is working to cover BEGRIVAC vaccine shortfall with other non-U.S. influenza virus vaccines
--No change to financial guidance
Chiron Corporation (Nasdaq:CHIR) today announced that it has reduced its supply expectations for its BEGRIVAC(TM) influenza virus vaccine for the 2005-2006 influenza season by approximately 8 million doses and may delay shipments until early October. Chiron had expected to supply approximately 12 million doses of BEGRIVAC vaccine to customers outside of the United States. Chiron now expects to supply approximately 4 million doses of BEGRIVAC vaccine in these ...